All News

malar lupus

Factors Predictive of SLE Flare After HCQ Taper/Discontinuation

d MedPage Today

The benefits of hydroxychloroquine in lupus are many, but if you were to withdraw HCQ? A recent study of five Canadian cohorts, suggests that certain baseline variables, including age, race, and steroid use,  were predictive of flare in patients with SLE who tapered or discontinued treatment with hydroxychloroquine.

Read Article
Telemedicine black computer

Inequities in Telemedicine During COVID-19

d MedPage Today

Health equity in the telehealth age has assumed added importance since the COVID-19 pandemic began. The Federal Communications Commission estimates that about 21 million Americans don't have access to the Internet in their homes. Other sources estimate it is closer to 162 million.

Read Article
travel3.jpg

Travel During COVID-19 Pandemic

d Jack Cush, MD

The CDC has addressed the effects and the issues of domestic and international travel on its website.  Below is a sampling of key advice.

Read Article
ACR Convergence 2020 Fireside Chats – top presentations in Still’s disease Sponsored by Novartis Medical Affairs Unable to attend all the key sessions at ACR Convergence 2020? Listen to the experts as they present their views on the top abstracts. https://t.co/MD6lU5oIvy https://t.co/CHRy3yeTwN

Links:

Dr. John Cush RheumNow ( View Tweet)
Pooled analysis of 16 RCTs in 7044 abatacept treated pts (21,274 PYs exposure) found very low risk of opportunistic infections ranging from OIs 0.17 to 0.21 on ABA and 0.56 on placebo - only 13 TB cases; IR for H zoster was low 1.53/100PY https://t.co/kOWYxEmQLd

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - Raynaud's or Not Lessons from the clinic an evaluation of blue fingers https://t.co/5EOvoM5jVf

Links:

Dr. John Cush RheumNow ( View Tweet)

Travel During COVID-19 Pandemic--The CDC has addressed the effects and the issues of domestic and international travel on its website. Read the full article for more information. https://t.co/wtn5dV6swM https://t.co/0HdC5CfUop

Links:

Dr. John Cush RheumNow ( View Tweet)
44 pts of Inclusion body myositis were randomized to either PBO or sirolimus 2 mg/d. At 12 mos there were no signif differences betw groups for motor strength , but sirolimus had more SAEs (45 vs 27%); yet sirolimus had better HAQ, FVC & 6-min walk times. https://t.co/YhnRTnaGFl

Links:

Dr. John Cush RheumNow ( View Tweet)

The NEJM has featured an overview of Osteoarthritis of the Knee. https://t.co/1AaNICygOr

Links:

Dr. John Cush RheumNow ( View Tweet)

Belated congratulations to Dr. David T. Felson, for receiving the Lee C. Howley, Sr. Prize for Arthritis Science from the Arthritis Foundation. He is a professor of medicine and epidemiology at Boston University's Schools of Medicine and Public Health https://t.co/U7yKnWWLxc

Links:

Dr. John Cush RheumNow ( View Tweet)

ACR Convergence 2020 Fireside Chats- top presentations in nr-axSpA, AS, axial PsA and Still’s disease. Sponsored by Novartis Medical Affairs Unable to attend the key sessions at #ACR20? Listen to the experts as they weigh in on the top abstracts. https://t.co/cUj5T3reyG

Links:

Dr. John Cush RheumNow ( View Tweet)

New QD Clinic—This week’s videos: Clinic Emergencies, Stopping Meds, 3 Issues After COVID Vaccination, My New Clinic COVID Routine, Raynaud's or Not https://t.co/R0zcRq6Sg1

Links:

Dr. John Cush RheumNow ( View Tweet)

Copay Assistance Programs Help Patients but Confuse Them Too https://t.co/WuPkwrE3ZF

Links:

Dr. John Cush RheumNow ( View Tweet)

Type I interferon (IFN1) produced by plasmacytoid dendritic cells are prime drivers of adaptive immunity. Study of 137 SLE pts shows that baseline IFN1 scores correl w/ Dz activity, # flares, prednisone doses, immunosuppressive use over 5 yrs https://t.co/OGb4NfrcIU

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast Now UP – Steroids, IVIG & the Vaccine. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more... https://t.co/f0wWTm2kV5

Links:

Dr. John Cush RheumNow ( View Tweet)

New Download Available on COVID-19 & mRNA Vaccines https://t.co/mvmn17Fl3B https://t.co/ceICzbDZi5

Links:

Dr. John Cush RheumNow ( View Tweet)
QD Clinic - What to do After COVID Vaccination https://t.co/25RcMOdAkK https://t.co/EWnYJGNqvY

Links:

Dr. John Cush RheumNow ( View Tweet)
2020 Rheumatology Year in Review-- Read our top news items that rheumatologists should recollect and integrate into clinical standards for 2021 and beyond. https://t.co/QisCpdcLEa https://t.co/pZekUvcomE

Links:

Dr. John Cush RheumNow ( View Tweet)
Rheumatologists: Record your question or case for the RheumNow podcast. https://t.co/wzNmOzH4VE https://t.co/dgTTvRqESI

Links:

Dr. John Cush RheumNow ( View Tweet)
ProDERM Study: IVIG in Dermatomyositis--The ProDERM study show that IVIg is safe, effective and superior to placebo in patients with dermatomyositis (DM). https://t.co/HOB8CYn9yc https://t.co/AmT3AQdawa

Links:

Dr. John Cush RheumNow ( View Tweet)
×